| LincRNA | Long intergenic non-coding RNA |
| DDR | DNA damage response |
| 5-FU | 5-Fluorouracil |
| OXP | Oxaliplatin |
| CIS | Cisplatin |
| CAR | Carboplatin |
| CSC | Cancer stem cell |
| PAC | Paclitaxel |
| ETO | Etoposide |
| DXR | Doxorubicin |
| RT-qPCR | Reverse transcription quantitative PCR |
| CPM | Counts per million |
| FC | Fold change |
| FDR | False discovery rate |
| CRC | Colorectal cancer |
| COAD | Colon adenocarcinoma |
| LUAD | Lung adenocarcinoma |
| NB | Neuroblastoma |
| OS | Osteosarcoma |
| ILF | Immortalized fetal lung fibroblasts |
| GEP-NET | Gastro-entero-pancreatic neuroendocrine tumor |
| LINC00973 KD | CRISPR-induced LINC00973 knockdown in PXK/HT-29 cells |
| PXK | HT-29 subclone derived from a single HT-29 cell, transfected with an empty plasmid PX459 |